From: Establishing a reasonable price for an orphan drug
All costs decrease in the same proportion than the R&D cost
Only R&D costs decrease for ultra-orphan drugs
Orphan cut-off point
£37,534
£39,260
Ultra-orphan cut-off point
£938,358
£981,507